BMRN vs BRSP · P/E 40, rev $1.76B vs rev $168.7M
Biomarin Pharmaceutical Inc (BMRN) versus Brightspire Capital Inc (BRSP) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Brightspire Capital Inc (BRSP) is a reit - mortgage company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported BRSP revenue for 2026-06-30 was $168.7M. Net income was -$13.5M. Revenue was up 98.1% from 2026-03-31 to 2026-06-30. BRSP currently screens at market cap $723.0M.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. BRSP currently screens at market cap $723.0M.
Not investment advice. Open the BMRN and BRSP stock pages for the full models.
Not investment advice.